A major problem in assessing the long-term outcome of HCV-infected cirrhotic patients with successfully treated Barcelona Clinic Liver Cancer (BCLC) A hepatocellular carcinoma (HCC) arises from the lack of models accounting for early changes during follow-up. Survival in hepatitis C virus (HCV) infected patients with cirrhosis and successfully treated hepatocellular carcinoma (HCC), is mainly influenced by early hepatic decompensation. HCV eradication after treatment with new direct-acting antiviral agents could improve overall survival of HCC patients through long-term preservation of liver function.
Hepatic Decompensation is the Major Driver of Death In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma / Cabibbo, Giuseppe; Petta, Salvatore; Barbara, Marco; Attardo, Simona; Bucci, Laura; Farinati, Fabio; Giannini, Edoardo G; Negrini, Giulia; Ciccarese, Francesca; Lodovico Rapaccini, Gian; Di Marco, Maria; Caturelli, Eugenio; Zoli, Marco; Borzio, Franco; Sacco, Rodolfo; Virdone, Roberto; Marra Mega, Fabio Andrea; Morisco, Filomena; Benvegnù, Luisa; Gasbarrini, Antonio; Svegliati Baroni, Gianluca; Giuseppe Foschi, Francesco; Olivani, Andrea; Masotto, Alberto; Nardone, GERARDO ANTONIO PIO; Colecchia, Antonio; Persico, Marcello; Craxì, Antonio; Trevisani, Franco; Cammà, Calogero. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 67:1(2017), pp. 65-71. [10.1016/j.jhep.2017.01.033]
Hepatic Decompensation is the Major Driver of Death In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
MORISCO, FILOMENA;NARDONE, GERARDO ANTONIO PIO;
2017
Abstract
A major problem in assessing the long-term outcome of HCV-infected cirrhotic patients with successfully treated Barcelona Clinic Liver Cancer (BCLC) A hepatocellular carcinoma (HCC) arises from the lack of models accounting for early changes during follow-up. Survival in hepatitis C virus (HCV) infected patients with cirrhosis and successfully treated hepatocellular carcinoma (HCC), is mainly influenced by early hepatic decompensation. HCV eradication after treatment with new direct-acting antiviral agents could improve overall survival of HCC patients through long-term preservation of liver function.| File | Dimensione | Formato | |
|---|---|---|---|
|
Hepatic decompensation- Morisco F, Nardone G.pdf
solo utenti autorizzati
Descrizione: articolo principale
Tipologia:
Versione Editoriale (PDF)
Licenza:
Accesso privato/ristretto
Dimensione
631.27 kB
Formato
Adobe PDF
|
631.27 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
